title: Timing of the components of the HIV life cycle in productively infected CD4+ T cells in a population of HIV-infected individuals.
abstract: We estimate the time required for HIV to complete separate stages of its infection cycle in productively infected CD4+ T cells in vivo by comparing initial delays after administration of single antiretroviral drugs until HIV RNA reduction in peripheral blood. Data were obtained from monotherapy studies of eight antiretroviral drugs from all currently licensed HIV drug classes: CCR5 blockers (maraviroc), fusion inhibitors (enfuvirtide), nucleoside and nonnucleoside reverse transcriptase inhibitors (abacavir, tenofovir, and rilpivirine), integrase inhibitors (raltegravir), and protease inhibitors (ritonavir and nelfinavir). We find that HIV requires an average of 52 h between export of virions in one generation to export in the next, with most of this (33 h) taken up by reverse transcription. Reverse transcription in vivo was three times longer than in vitro and began soon after virion fusion, as we determined no difference in mean times for commencement of reverse transcription and virion fusion as calculated by timing of the effects for tenofovir and maraviroc. Approximately 7 h is required between HIV integration and virion production. First-phase HIV RNA decay (half-life of 17 h over all drugs) seemed to slow as the stage being inhibited by the drug was further from viral production. The mean estimated half-life of plasma virions was 5 min, significantly shorter than previous estimates.
authors.affiliation: School of Mathematics and Statistics, University of New South Wales, Sydney 2052, NSW, Australia. J.Murray@unsw.edu.au
authors.forename: John M
authors.initials: JM
authors.lastname: Murray
authors.forename: Anthony D
authors.initials: AD
authors.lastname: Kelleher
authors.forename: David A
authors.initials: DA
authors.lastname: Cooper
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage; D015496:CD4-Positive T-Lymphocytes / Q000821:virology*; D006678:HIV / Q000254:growth & development / Q000502:physiology*; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D006801:Humans; D013997:Time Factors; D053586:Virus Internalization; D057074:Virus Release; D014779:Virus Replication
chemical_list: D019380:Anti-HIV Agents